187 related articles for article (PubMed ID: 29255095)
21. Relevant prognostic factors in patients with stage IV small intestine neuroendocrine neoplasms.
Maurer E; Heinzel-Gutenbrunner M; Rinke A; Rütz J; Holzer K; Figiel J; Luster M; Bartsch DK
J Neuroendocrinol; 2022 Jan; 34(1):e13076. PubMed ID: 34964186
[TBL] [Abstract][Full Text] [Related]
22. Clinicopathologic characteristics and prognosis of gastroenteropancreatic neuroendocrine neoplasms: a multicenter study in South China.
Fang C; Wang W; Zhang Y; Feng X; Sun J; Zeng Y; Chen Y; Li Y; Chen M; Zhou Z; Chen J
Chin J Cancer; 2017 Jun; 36(1):51. PubMed ID: 28637502
[TBL] [Abstract][Full Text] [Related]
23. Intra-abdominal fibrosis in a recent cohort of patients with neuroendocrine ('carcinoid') tumours of the small bowel.
Druce MR; Bharwani N; Akker SA; Drake WM; Rockall A; Grossman AB
QJM; 2010 Mar; 103(3):177-85. PubMed ID: 20123681
[TBL] [Abstract][Full Text] [Related]
24. Extent of Lymph Node Dissection for Small Bowel Neuroendocrine Tumors.
Hallet J; Law C;
World J Surg; 2021 Jan; 45(1):197-202. PubMed ID: 32737557
[TBL] [Abstract][Full Text] [Related]
25. Survival outcomes and surgical intervention of small intestinal neuroendocrine tumors: a population based retrospective study.
Wu L; Fu J; Wan L; Pan J; Lai S; Zhong J; Chung DC; Wang L
Oncotarget; 2017 Jan; 8(3):4935-4947. PubMed ID: 27903960
[TBL] [Abstract][Full Text] [Related]
26. Sexual Dimorphism in Small-intestinal Neuroendocrine Tumors: Lower Prevalence of Mesenteric Disease in Premenopausal Women.
Blažević A; Iyer AM; van Velthuysen MF; Hofland J; Oudijk L; de Herder WW; Hofland LJ; Feelders RA
J Clin Endocrinol Metab; 2022 Apr; 107(5):e1969-e1975. PubMed ID: 34999838
[TBL] [Abstract][Full Text] [Related]
27. EndoVascular Occlusion and Tumor Excision (EVOTE): a Hybrid Approach to Small-Bowel Neuroendocrine Tumors with Mesenteric Metastases.
Horwitz JK; Marin ML; Warner RRP; Lookstein RA; Divino CM
J Gastrointest Surg; 2019 Sep; 23(9):1911-1916. PubMed ID: 31090038
[TBL] [Abstract][Full Text] [Related]
28. Surgical Management of Small Bowel Neuroendocrine Tumors: Specific Requirements and Their Impact on Staging and Prognosis.
Pasquer A; Walter T; Hervieu V; Forestier J; Scoazec JY; Lombard-Bohas C; Poncet G
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S742-9. PubMed ID: 26014153
[TBL] [Abstract][Full Text] [Related]
29. Should Ki67 immunohistochemistry be performed on all lesions in multifocal small intestinal neuroendocrine tumours?
Numbere N; Huber AR; Shi C; Cates JMM; Gonzalez RS
Histopathology; 2019 Feb; 74(3):424-429. PubMed ID: 30326145
[TBL] [Abstract][Full Text] [Related]
30. Effect of primary tumour resection without curative intent in patients with metastatic neuroendocrine tumours of the small intestine and right colon: meta-analysis.
Van Den Heede K; Chidambaram S; Van Slycke S; Brusselaers N; Warfvinge CF; Ohlsson H; Nordenström E; Almquist M
Br J Surg; 2022 Feb; 109(2):191-199. PubMed ID: 34941998
[TBL] [Abstract][Full Text] [Related]
31. Should mesenteric tumor deposits be included in staging of well-differentiated small intestine neuroendocrine tumors?
Gonzalez RS; Liu EH; Alvarez JR; Ayers GD; Washington MK; Shi C
Mod Pathol; 2014 Sep; 27(9):1288-95. PubMed ID: 24457461
[TBL] [Abstract][Full Text] [Related]
32. Survival and disease recurrence in patients operated for small intestinal neuroendocrine tumors at a referral hospital.
Folkestad O; Wasmuth HH; Mjønes P; Fougner R; Hauso Ø; Fossmark R
Surg Oncol; 2020 Dec; 35():336-343. PubMed ID: 32979699
[TBL] [Abstract][Full Text] [Related]
33. Prognostic Factors Associated with Outcomes in Small Bowel Neuroendocrine Tumors.
Manguso N; Johnson J; Harit A; Nissen N; Mirocha J; Hendifar A; Amersi F
Am Surg; 2017 Oct; 83(10):1174-1178. PubMed ID: 29391119
[TBL] [Abstract][Full Text] [Related]
34. Indication for liver transplantation in young patients with small intestinal NETs is rare?
Norlén O; Daskalakis K; Öberg K; Åkerström G; Stålberg P; Hellman P
World J Surg; 2014 Mar; 38(3):742-7. PubMed ID: 24233660
[TBL] [Abstract][Full Text] [Related]
35. Predicting Survival of Small Intestine Neuroendocrine Tumors: Experience From a Major Referral Center.
Kelly S; Aalberg J; Agathis A; Phillips K; Haile S; Haines K; Kang Kim M; Divino CM
Pancreas; 2019 Apr; 48(4):514-518. PubMed ID: 30946234
[TBL] [Abstract][Full Text] [Related]
36. Laparoscopic assisted central mesenteric lymph node dissection with bowel sparing resection of small bowel neuroendocrine tumours using fluorescence angiography - a video vignette.
Kaçmaz E; Slooter MD; Nieveen van Dijkum EJM; Tanis PJ; Engelsman AF
Colorectal Dis; 2019 Jun; 21(6):724-725. PubMed ID: 30895686
[No Abstract] [Full Text] [Related]
37. Role of Staging in Patients with Small Intestinal Neuroendocrine Tumours.
Clift AK; Faiz O; Al-Nahhas A; Bockisch A; Liedke MO; Schloericke E; Wasan H; Martin J; Ziprin P; Moorthy K; Frilling A
J Gastrointest Surg; 2016 Jan; 20(1):180-8; discussion 188. PubMed ID: 26394880
[TBL] [Abstract][Full Text] [Related]
38. Melatonin Immunoreactivity in Malignant Small Intestinal Neuroendocrine Tumours.
Söderquist F; Janson ET; Rasmusson AJ; Ali A; Stridsberg M; Cunningham JL
PLoS One; 2016; 11(10):e0164354. PubMed ID: 27736994
[TBL] [Abstract][Full Text] [Related]
39. A nomogram to assess small-intestinal neuroendocrine tumor ('carcinoid') survival.
Modlin IM; Gustafsson BI; Pavel M; Svejda B; Lawrence B; Kidd M
Neuroendocrinology; 2010; 92(3):143-57. PubMed ID: 20733279
[TBL] [Abstract][Full Text] [Related]
40. Prognostic impact of a large mesenteric mass >2 cm in ileal neuroendocrine tumors.
Kasai Y; Mahuron K; Hirose K; Corvera CU; Kim GE; Hope TA; Shih BE; Warren RS; Bergsland EK; Nakakura EK
J Surg Oncol; 2019 Dec; 120(8):1311-1317. PubMed ID: 31613999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
